Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.024 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |